Treatment of Diabetic Foot with Heberprot-P ®

Cuba has successfully developed the Heberprot-P ®, a new and unique drug to treat the diabetic foot ulcer, a common complication in people that suffer from Diabetes Mellitus. This product has been registered in 19 countries and it contains Recombinant Human Epidermal Growth Factor. It reduces the relative amputation risk in nearly 78 percent of cases.